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Abstract
Background: Patients with schizophrenia have difficulty managing their medical healthcare needs,
possibly resulting in delayed treatment and poor outcomes. We analyzed whether patients reduced
primary care use over time, differentially by diagnosis with schizophrenia, diabetes, or both
schizophrenia and diabetes. We also assessed whether such patterns of primary care use were a
significant predictor of mortality over a 4-year period.
Methods: The Veterans Healthcare Administration (VA) is the largest integrated healthcare
system in the United States. Administrative extracts of the VA's all-electronic medical records were
studied. Patients over age 50 and diagnosed with schizophrenia in 2002 were age-matched 1:4 to
diabetes patients. All patients were followed through 2005. Cluster analysis explored trajectories
of primary care use. Proportional hazards regression modelled the impact of these primary care
utilization trajectories on survival, controlling for demographic and clinical covariates.
Results: Patients comprised three diagnostic groups: diabetes only (n = 188,332), schizophrenia
only (n = 40,109), and schizophrenia with diabetes (Scz-DM, n = 13,025). Cluster analysis revealed
four distinct trajectories of primary care use: consistent over time, increasing over time, high and
decreasing, low and decreasing. Patients with schizophrenia only were likely to have low-decreasing
use (73% schizophrenia-only vs 54% Scz-DM vs 52% diabetes). Increasing use was least common
among schizophrenia patients (4% vs 8% Scz-DM vs 7% diabetes) and was associated with improved
survival. Low-decreasing primary care, compared to consistent use, was associated with shorter
survival controlling for demographics and case-mix. The observational study was limited by reliance
on administrative data.
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BMC Health Services Research 2009, 9:127 http://www.biomedcentral.com/1472-6963/9/127Conclusion: Regular primary care and high levels of primary care were associated with better
survival for patients with chronic illness, whether psychiatric or medical. For schizophrenia
patients, with or without comorbid diabetes, primary care offers a survival benefit, suggesting that
innovations in treatment retention targeting at-risk groups can offer significant promise of
improving outcomes.
Background
Excess mortality has been documented among patients
with schizophrenia, [1] and indeed schizophrenia has
been estimated in community-based studies to be associ-
ated with up to 25 years' shorter lifespan. [2] Mortality
rates for all causes, natural causes, and unnatural causes
are all higher than expected among schizophrenia
patients relative to the general population. [3]
Medical comorbidity among aging schizophrenia patients
is common, the result of poor health behaviors, medica-
tion side effects, and schizophrenia itself, in addition to
the usual functional and health status declines associated
with aging. [4-7] Diabetes, in particular, represents a sig-
nificant medical illness among individuals with psychiat-
ric conditions. This comorbidity affects about 20% of all
VA patients with or without a serious mental illness. In
2002, nearly 670,000 veterans over age 50 received care
for diabetes in the VA, including 13,000 with schizophre-
nia.
The benefits of primary care for patients in general and for
patients with a complex chronic illness, specifically, have
been well documented. Multiple studies demonstrate a
relationship between availability of primary care and
mortality. [8,9] In small geographic areas where access to
primary care is better, people are more likely to report
improved overall health. [10] Delivery of high quality pri-
mary care is associated with a reduction in racial/ethnic
health disparities for both physical and mental health. [8]
Studies in both the U.S. and other countries consistently
find that population health is better where there are more
primary care providers. [9] Among patients with type 2
diabetes, higher levels of continuity with a primary care
provider are associated with improved glucose control.
[10] Furthermore, when primary care delivery is more
consistent with the chronic care model, patients with dia-
betes have a reduction in likelihood of developing coro-
nary heart disease. [11]
Although the delivery of primary care has documented
benefit, health services use by patients with schizophrenia
is frequently suboptimal. In the VA, veterans with schizo-
phrenia are almost 40% less likely to have visited a pri-
mary care provider compared to patients without a
psychiatric diagnosis over a one-year period. [12] Moreo-
ver, patients with schizophrenia are less likely to remain
engaged in appropriate health care, although when men-
tally ill patients are "well-engaged" in care, appropriate
care is more likely. [13-15] Dixon's research group noted
diminished quality of care for patients with both serious
mental illness (schizophrenia or major mood disorder)
and diabetes, relative to patients with diabetes alone, in
their study of quality indicators. [16] This is a troubling
finding in view of the high level of risk factors for diabetes
among VA patients with serious mental illness. Among
inpatient decedents, loss of contact with the VA healthcare
system for the year-long prior period was associated with
increased risk of unforeseen death and was more common
among patients with schizophrenia (20%) than among
other decedents (8%). [17] If loss of system contact pre-
dicts subsequent increased risk of unforeseen death
among inpatients, does decreased primary care put outpa-
tients at increased risk? Seminal risk factors for mortality
such as primary care utilization among the population of
VA outpatients with schizophrenia should be identified to
permit outreach to those patients at high risk of death.
The purpose of this study was to examine the relation-
ships between patterns of primary care and mortality
across three groups of patients: those with schizophrenia
only, diabetes only, or both conditions.
Methods
Study Design
The local institutional review board approved the study
prior to its commencement. Patient data for 241,508 VA
patients with schizophrenia and/or diabetes were
extracted from administrative sources (fiscal years 2002 –
2005) to provide measures of patient characteristics and
care in the VA for this retrospective cohort study.
Sample
Patients included in the study were aged 50 or older on
Oct. 1, 2001 (fiscal year 2002 runs from October 2001
through September 2002) and carried a diagnosis of
schizophrenia, diabetes mellitus, or both schizophrenia
and diabetes (Scz-DM). Patients were considered to have
schizophrenia if they had an ICD-9 code of 295.xx
(excluding latent schizophrenia 295.5x) from at least one
VA inpatient stay or at least two VA outpatient visits on
different dates, based on the methods of the VA's NationalPage 2 of 11
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patients in contact with the healthcare system at baseline,
and thus may not fully include intermittent users.
Patients with schizophrenia typically have other psychiat-
ric conditions in the medical record. Patients with schizo-
phrenia who were also diagnosed with schizoaffective
disorder or other serious mental illness, including bipolar
disorder, major depressive disorder, other psychosis, and
post-traumatic stress disorder (ICD-9 codes 295.7; 296.0,
296.1, 296.4–296.8; 296.2–296.3; 297–298; 309.81) but
were treated primarily for schizophrenia, as described
above, were retained in the sample. Patients diagnosed
more frequently with a serious mental illness other than
schizophrenia or schizoaffective disorder (i.e., bipolar dis-
order, major depressive disorder, other psychosis, or post-
traumatic stress disorder) were excluded from the study.
[18]
Patients were identified as having diabetes if they had an
ICD-9 code of 250.xx, 357.2x, 362.0x, or 366.41 on at
least two different outpatient care dates in fiscal 2002 at
least 30 days apart, consistent with diagnostic validity
research. [19] Diabetes-only patients were limited to
those without diagnosed serious mental illness, as defined
above. Because of the very large number of diabetes
patients, patients diagnosed with diabetes and no serious
mental illness were randomly sampled and age-matched
1 to 4 with patients with schizophrenia.
Data Sources
This study used archival data extracted from the VA's all-
electronic medical record detailing patients' use of VA
hospitals, extended care facilities, and outpatient clinics,
as well as prescription medications, laboratory tests, and
enrolment status. In the VA vital status database, date of
death is based on VA, Social Security Administration, and
US National Death Index records per a validated algo-
rithm with demonstrated sensitivity of 98%. [20] The VA
vital status database does not report cause of death.
Measures
Race, gender, and marital status were recoded from medi-
cal record extracts as indicators of Hispanic, black, and
missing race data, female gender, and married vs divorced
vs widowed vs never married at baseline. Age was calcu-
lated as of the beginning of the study period, October 1,
2001. Date of death was used to calculate survival from
the beginning of the study period.
The outpatient healthcare parameter of interest, primary
care, was assessed by totalling the number of days each
year on which patients had primary care visits (includes
geriatric primary care and women's clinic). The trajectory
of primary care use was captured by a cluster analysis of
the number of primary care visits per year over the four
years of the study. There are several advantages to this
approach compared to total counts of visits. First, this
approach permits inspection of differential use of primary
care within years as well as across years, in contrast with
the standard approach of analyzing across years only. In
addition, this allows one to group patients according to
their trajectory of primary care use, rather than by total
utilization. The method is further described in the Analy-
sis section.
Loss of system contact was determined from enrolment
files for each follow-up fiscal year and summarized in an
indicator (yes/no) denoting loss of contact during FY03–
FY05, where patients scoring 0 or "no" were seen in the VA
at least once during each year, and those scoring 1 were
alive but had no VA care during at least one follow-up
year.
In addition to the index diagnosis, measures of other ill-
ness were derived from ICD-9 codes on inpatient and out-
patient records, including the Selim comorbidity indices.
The Selim physical comorbidity index counts 30 medical
conditions, although we excluded diabetes which was
captured separately by diagnosis group. The indices were
developed with self-report data, and have been operation-
alized and validated in VA administrative data. [21,22]
We also counted the number of drug classes for which
patients had VA prescriptions during each year, as this has
been found to be a good proxy for comorbidity burden.
[23] Interestingly, this measure was not highly collinear
with the Selim index (variance accounted for = 28%).
Veteran priority score is assigned by the VA to veterans to
determine eligibility for VA healthcare. It is associated
with physical and mental health status, and it appears to
be a proxy for socioeconomic status and disease severity.
[24] It incorporates service-connected disability, a rating
of how related a veteran's illness is to his/her military serv-
ice, described in increments of 10% from 0% to 100%.
The categories of VA priority status are: service-connected
disability of 50% or more (category 1), service-connected
disability 30% or 40% (category 2), former POWs, Purple
Heart recipients, 10% or 20% disability (category 3), cat-
astrophically disabled (category 4), very low income (cat-
egory 5), special era-related status/0% service-connected
disability (category 6), and non-service-connected status
(categories 7, 8). [22,25] Priority 1 patients have no co-
pays for VA care or prescriptions. At the time of this study,
Priority 2–6 patients had co-pays for some VA care and for
VA prescriptions; Priority 7–8 had co-pays for care and
prescriptions.
Analysis
Descriptive frequencies and means were prepared. We
used cluster analysis to identify patterns of health services
utilization, logistic regression to assess the relationshipPage 3 of 11
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hazards to analyze associations with survival in the study
period.
The cluster analysis explored the possibility of different
trajectories of health care use within the sample. Cluster
analysis classifies respondents by the pattern or profile
defined by their values on specific variables (e.g., primary
care visits each year). The profiles may differ in shape or
scale. A difference in shape might indicate consistent val-
ues over time (a flat line) or might indicate successively
increasing values over time (a sloped line). A difference in
scale might occur when one group has consistently high
scores while another has consistently low scores. In this
type of cluster analysis, the distance between cases (per-
sons) is calculated based on their values on the variables
of interest (number of primary care visits during each of
four years), and cases that are closest together in Euclidean
space, i.e., that have the most similar pattern of values, are
clustered together. The cluster analysis begins by cluster-
ing the closest pair, then forms the next cluster treating the
first pair as a single unit, and so on until the number of
clusters reduces from the number of cases (241,466) to
the number of clusters with Eigenvalues greater than 1 (in
this case, 4).
We did not impose a specific structure on the shapes of the
trajectories over time. Thus for each cluster, the mean
slope of the trajectory each year was the difference of the
mean number of primary care visits between adjacent
years, which could vary across years. To handle the large
dataset, we executed a preliminary clustering to produce
20 clusters (PROC FASTCLUS, which optimizes process-
ing by not assessing Eigenvalues) followed by a standard
cluster analysis of the preliminary clusters, allowing the
data to dictate the number of clusters in the final analysis
(those with Eigenvalues greater than 1). We then
inspected the proximity coefficients and the theoretical
meaningfulness of the solutions. Ward's method, which
uses squared Euclidean distances as a proximity measure,
identified the cluster solutions. This method maximizes
within-group homogeneity and between-group heteroge-
neity, and does not require pre-specification of the
number of clusters. [26,27]
Logistic regression models assessed the relationship
between death and patterns of care, adjusting for covari-
ates (listed below). Logistic regression model fit was
assessed by the concordance c-statistic, which ranges from
0.50 (no improvement over null) and 1.0 indicating per-
fect fit. Hazard ratios were estimated for primary care clus-
ter by a Cox proportional hazards model, adjusting for
covariates. Survival analysis modelled years survived from
the beginning of the study period as a function of patterns
of care (primary care cluster). Predictors included diag-
nostic group (schizophrenia, Scz-DM, diabetes), age as of
October 1 2001, race, gender, marital status, loss of sys-
tem contact, VA priority status, Selim physical comorbid-
ity score, and number of medication classes prescribed in
the baseline year. An interaction term of cluster by diagno-
sis was included to determine whether use of primary care
had a differential impact on mortality over the 4-year
study, for patients with schizophrenia, diabetes or both
conditions.
Results
Sample
A total of 242,898 VA patients met eligibility criteria.
Patients without valid priority status were considered to
be non-veterans and were excluded from the study (n =
1,390); another 42 cases were dropped for utilization
more than 31 days after date of death (post-mortem
bereavement counselling is offered by the VA; continued
illogical use suggests error). The final sample numbered
241,466 VA patients
There were 53,134 schizophrenia patients aged ≥ 50 years
with valid priority status receiving care in the VA in FY02.
These patients were age-matched in a 4:1 ratio with diabe-
tes patients (n = 188,332). During matching, it was noted
that there were not enough diabetes patients aged 50–52
to match 4:1 for all schizophrenia patients; this age group
matched 2.5 diabetes patients per 1 schizophrenia
patient. Among patients with schizophrenia, 25% (n =
13,025) were also diagnosed with diabetes leaving 40,109
patients in the schizophrenia-only group.
The sample included 2.2% female veterans and ranged in
age from 50 to 104 years (mean = 60.7; SD = 9.5). Twenty-
one percent (21%) of patients were of non-white race/eth-
nicity (African-American, Hispanic), 53% were white, and
26% had missing data on this measure. Over the 4 years
of the study, 5.5% of patients were not seen in the VA dur-
ing one or more fiscal years in which they were alive;
14.5% of the patients died (see Table 1).
Characteristics varied by diagnostic group. Patients with
diabetes only were more likely to be married (63%) or
widowed (5.2%) compared to schizophrenia patients,
whereas patients with schizophrenia, regardless of diabe-
tes status, were more likely to have never married (diabe-
tes 10% vs Scz-DM 34% vs schizophrenia 42%; chi-
square(6) = 32,140; p < .0001). Patients diagnosed with
schizophrenia were more likely to be female (schizophre-
nia: 3.4% female, Scz-DM: 3.4% female, diabetes: 1.8%
female; chi-square(2) = 478; p < .0001). Diabetes patients
had the lowest rates of death (13.7%; chi-square(2) = 589;
p < .0001), compared to schizophrenia patients (16.3%)
and Scz-DM patients (20.6%). Average primary care use
(mean, SD) is shown in Figure 1.Page 4 of 11
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Characteristic Schizophrenia
Only
(n = 40,109)
Both
Schizophrenia
& Diabetes
(n = 13,025)
Diabetes Only
(n = 188,332)
Overall Sample
(N = 241,466)
Mean (SD)
Age (range 50–104 years) 59.8 (9.5) 60.4 (9.3) 61.0 (9.5) 60.7 (9.5)
Age at Death (n = 34,991) 68.1 (10.9) 67.7 (10.4) 68.6 (11.0) 68.5 (10.9)
N (%)
Female 1,359 (3.4) 439 (3.4) 3,429 (1.8) 5,227 (2.2)
Race/Ethnicity
Hispanic 2,786 (7.0) 1,411 (10.8) 10,440 (5.5) 14,637 (6.1)
Black 8,482 (21.2) 3,532 (27.1) 23,745 (12.6) 35,759 (14.8)
White 24,195 (60.3) 6,920 (53.1) 96,084 (51.0) 127,199 (52.7)
Other/unknown 4,286 (10.7) 1,003 (7.7) 56,451 (30.0) 61,740 (25.6)
Marital Status
Married 9,806 (24.5) 4,286 (32.9) 117,870 (62.6) 131,962 (55.3)
Divorced 11,462 (28.6) 3,608 (27.7) 39,351 (20.9) 54,421 (22.8)
Never married 16,481 (41.1) 4,338 (33.3) 19,536 (10.4) 40,355 (16.9)
Widowed 1,683 (4.2) 657 (5.0) 9,751 (5.2) 12,091 (5.1)
Diagnosis Group 40,223 (16.6) 13,057 (5.4) 189,618 (78.1) --
Diagnosis of Hypertension 14,187 (35.4) 8,252 (63.4) 139,214 (73.9) 161,653 (67.0)
Diagnosis of Hyperlipidemia 9,300 (23.2) 5,590 (42.9) 103,965 (55.2) 118,855 (49.2)
Diagnosis of Dementia 1,123 (2.8) 414 (3.2) 1,142 (0.6) 2,679 (1.1)
Any Inpatient Admission over study period 21,550 (53.7) 8,137 (62.5) 63,317 (33.6) 93,004 (38.5)
Priority Category
Category 1: 50–100% disabled 20,705 (51.6) 7,440 (57.1) 55,106 (29.3) 83,251 (34.5)
Category 2: 30–40% disabled 1,226 (3.1) 467 (3.6) 13,268 (7.1) 14,961 (6.2)
Category 3: 10–20% disabled, former POW, Purple Heart 1,694 (4.2) 707 (5.4) 18,086 (9.6) 20,487 (8.5)
Category 4: Catastrophically disabled 8,188 (20.4) 2,248 (17.3) 12,905 (6.9) 23,341 (9.7)Page 5 of 11
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among diabetes patients relative to schizophrenia patients
(diabetes 30% vs Scz-DM 8% vs schizophrenia 11% miss-
ing race data; chi-square(2) = 8774; p < .0001). In VA
databases in 2002, race was recorded by a clinical observer
in inpatient records and was rarely missing, while outpa-
tient records were characterized by high rates of missing
data. Because patients with schizophrenia are likely to be
hospitalized for acute psychotic exacerbations, they had
more opportunity to receive a valid code on this measure.
Comorbidity
Among patients diagnosed with schizophrenia, 34% were
also diagnosed with schizoaffective disorder, post-trau-
matic stress disorder (7%), bipolar disorder (4%), major
depression (3%) or other psychosis (3%) on two or more
occasions in the baseline year.
The Selim physical comorbidity score, minus diabetes,
averaged 2.3 (SD = 1.6; range 0–15) for patients with dia-
betes alone, 2.1 (SD = 1.6; range 0–11) for patients with
both index conditions, but 1.4 (SD = 1.5; range 0–13) for
patients with schizophrenia alone. The average number of
medication classes for which patients received prescrip-
tions in the baseline year was 6.4 (SD = 4.5; range 0–33)
for schizophrenia-only patients, 10.0 (SD = 5.3; range 0–
36) for both conditions, 8.7 (SD = 4.7; range 0–42) for
diabetes-only.
Cluster Profiles
The preliminary cluster analysis produced 20 clusters with
between-centroid distances ranging from 3.6 to 345.5.
The final cluster analysis identified four distinct patterns
of primary care visits over the 4-year study period (shown
in figure 2). The first cluster depicted Increasing use of pri-
mary care from an average of 6 to 13 visits per year. The
second cluster contained patients whose trajectory of pri-
mary care use was Consistent, averaging approximately 4
visits per year. Cluster three profiled a trajectory of
decreasing use of primary care at a low level (Low-decreas-
ing), falling from about 3 visits per year to about 1.5 visits
per year. The fourth and final cluster described a trajectory
of high levels of primary care use decreasing sharply from
10 to 4.5 visits per year on average (High-decreasing).
While most patients were in the low-decreasing primary
care cluster, cluster membership differed by diagnostic
group, as illustrated in Figure 3. Patients with schizophre-
nia only were predominant in the Low-decreasing trajec-
tory, those with diabetes-only dominated the Consistent
use trajectory, and Scz-DM patients were the most numer-
ous group in both the Increasing and High-decreasing tra-
jectories. Consistent-use cluster membership was more
Category 5: Low income 7,748 (19.3) 2,037 (15.6) 64,662 (34.3) 74,447 (30.8)
Category 6: 0% disabled, special eras -- -- -- 781 (0.3)
Category 7–8: Non-service-connected status (copayment required) 504 (0.2) 117 (0.9) 23,577 (12.5) 24,198 (10.0)
Table 1: Sample Characteristics of VA Patients with Diabetes, Schizophrenia, or Both Diabetes and Schizophrenia (N = 241,466) 
Average Primary Care Use by VA Patients with Schizophre-nia, Diabetes, or Both Conditions over 4 Years (N = 241,508)Figure 1
Average Primary Care Use by VA Patients with 
Schizophrenia, Diabetes, or Both Conditions over 4 
Years (N = 241,508).
Primary Care Trajectories over the period FY02–FY05 for VA Patients with Schizophrenia, Diab tes, or Both Condi-tions (N = 241,508)Figure 2
Primary Care Trajectories over the period FY02–
FY05 for VA Patients with Schizophrenia, Diabetes, 
or Both Conditions (N = 241,508).Page 6 of 11
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Scz-DM (28%) or schizophrenia-only patients (19%).
Patients with schizophrenia were more likely to experi-
ence the low-decreasing trajectory of primary care, 73%
schizophrenia-only vs 54% Scz-DM vs 52% diabetes-only.
High-decreasing primary care use was associated with dia-
betes, with or without schizophrenia: 10% of Scz-DM
patients experienced this trajectory, 8% of diabetes
patients, and 4% of schizophrenia-only patients.
Mortality Models
An unadjusted model of mortality during the three years
of follow-up estimated increased relative odds of death
associated with membership in Low-decreasing primary
care use compared to the Consistent-use cluster (OR = 3.8,
95% CI 3.7–4.0). Compared to patients with Consistent
primary care use, patients in the Increasing-use trajectory
had lower relative odds of death (OR = 0.50, CI95 .45–
.55) while those with High-decreasing use had increased
odds of death (OR = 2.5, CI95 2.3–2.6). The unadjusted
model had a poor fit as assessed by the C-statistic of 0.64.
The adjusted model showed a significant interaction of
diagnosis by primary care cluster (Wald chi-square(6) =
70.9; p < .0001) and a good fit (C-statistic = 0.78), with
main effects of cluster and diagnosis. Additional factors
associated with death during follow-up included loss of
system contact (OR = 1.4), greater age (OR = 1.9 per dec-
ade), and increased comorbidity burden (OR = 1.1 per
Selim physical comorbidity; 95% confidence intervals
provided in Table 2). Being married (OR = 0.69) or female
(OR = 0.64) was protective. The changes in estimated
odds ratios from the unadjusted to the adjusted model
demonstrate that some variation in mortality risk is attrib-
utable to specific aspects of health care, including treat-
ment of multimorbidity and prescriptions, but significant
variation in mortality is attributable to variation in the use
of primary care. Relative odds of death associated with
membership in each diagnosis by primary care sub-group,
relative to a single reference group of diabetes with con-
sistent care, are shown in the table.
In the covariate-adjusted Cox proportional hazards model
of survival time, the interaction of primary care cluster by
diagnosis was again significant. Hazard rates of mortality
were similar within diagnosis groups for patients with
either Increasing or High-decreasing primary care. The
hazard ratio of mortality for schizophrenia and Scz-DM,
relative to diabetes only, was significantly greater when
the patient was experiencing low-decreasing primary care,
compared to other trajectories of primary care. Additional
risk of diminished survival was imparted by loss of system
contact (HR = 1.2), older age (HR = 1.7 per decade), and
more physical comorbidity (HR = 1.2 per point on the
Selim score). Marriage (HR = 0.74) and female gender
(HR = 0.69) were protective, as was Increasing primary
care use. Compared to consistent use-diabetes patients,
patients with increasing use were at much less risk of
shorter survival (HR = 0.26 for schizophrenia patients, HR
= 0.48 for Scz-DM patients, and HR = 0.38 for diabetes-
only patients). Survival curves are shown in Figure 4.
Discussion
Our cluster analysis approach to varying trajectories of
primary care use allowed us to examine administrative
data on a large sample of patients to distinguish impor-
tant subgroups of patients for their differential risk of
mortality. Survival was associated with patients' trajectory
of primary care use, with differential effects by diagnosis
group (schizophrenia only, diabetes only, both schizo-
phrenia and diabetes). Overall, the interaction effect of
diagnosis by primary care trajectory was primarily due to
significantly greater hazard ratios in the low-decreasing
cluster. Therefore, a pattern of primary care use that was
either consistent over time or high-decreasing over time
would be most likely to achieve optimal outcomes for
patients with schizophrenia. Conversely, effective inter-
vention with patients with low-decreasing primary care
should have the best chance of reducing premature mor-
tality, especially for patients with schizophrenia only as
that group appears to be over-represented in the trajec-
tory.
Why would decreasing use of primary care be associated
with higher risk of mortality? Starfield and Shi, in their
review of the benefits of primary care, postulate 6 mecha-
nisms that may account for the beneficial effects of pri-
mary care: 1) increased access to health care services
created by primary care for relatively deprived population
groups, such as those with schizophrenia; 2) enhance-
Trajectories of Primary Care Use by Older VA Patients with Chronic Di ease: Schizoph nia Only, Diabetes Only, or Both Schizophr n a & DiabetesFigure 3
Trajectories of Primary Care Use by Older VA 
Patients with Chronic Disease: Schizophrenia Only, 
Diabetes Only, or Both Schizophrenia & Diabetes.Page 7 of 11
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BMC Health Services Research 2009, 9:127 http://www.biomedcentral.com/1472-6963/9/127Table 2: Characteristics Associated with Decreased Survival among VA Patients with Diabetes, Schizophrenia, or Both Diabetes and 
Schizophrenia (N = 241,466)
Parameter Hazard Ratio Pr > ChiSq
Age in Decades (range 5–10) 1.72 <.0001
Female 0.69 <.0001
Married 0.74 <.0001
Black 0.99 0.5030
Hispanic 1.00 0.9348
Missing Data on Race 0.73 <.0001
Vietnam Era 1.05 0.0023
Priority Status – Referent: Priority 1
Priority Status 2 0.93 0.0046
Priority Status 3 0.96 0.0496
Priority Status 4 1.36 <.0001
Priority Status 5 1.01 0.5910
Priority Status 6 0.95 0.6357
Priority Status 7 0.79 <.0001
Priority Status 8 0.74 0.0582
Selim Physical Comorbidity Score (range 0–15) 1.10 <.0001
Number of Medication Classes at Baseline (range 0–42) 1.07 <.0001
Loss of System Contact During Study Period 1.17 <.0001
Primary Care Trajectory by Diagnosis Subgroups – Referent: Consistent Care – Diabetes Only
Increasing Primary Care – Schizophrenia 0.26 <.0001
Consistent Primary Care – Schizophrenia 0.95 0.2781
Low-Decreasing Primary Care – Schizophrenia 4.20 <.0001
High-Decreasing Primary Care – Schizophrenia 1.31 0.0002
Increasing Primary Care – Schizophrenia with Diabetes 0.48 <.0001
Consistent Primary Care – Schizophrenia with Diabetes 1.01 0.8176
Low-Decreasing Primary Care – Schizophrenia with Diabetes 5.01 <.0001
High-Decreasing Primary Care – Schizophrenia with Diabetes 1.44 <.0001Page 8 of 11
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delivered to the patient; 3) impact of primary care on pre-
vention; 4) impact of primary care on early management
of health problems; 5) accumulated contribution of pri-
mary care characteristics such as care coordination to
more appropriate care, for example, continuity of primary
care and coordination of care are associated with better
control of risk factors for cardiovascular disease such as
blood pressure and lipid levels, especially for patients
with diabetes; [11] and 6) the role of primary care in
reducing unnecessary care that may lead to harm. [9]
While schizophrenia-only patients in this study did not
have diabetes, they frequently had comorbid hyperten-
sion or hyperlipidemia and were at risk from diabetogenic
medications. [28]
Patients with decreasing primary care use may have sub-
stituted inpatient for outpatient care. In the VA, inpatients
may still receive care in the outpatient clinics, because
both types of care are provided in the larger facilities, mak-
ing it difficult to disentangle these measures, but inpatient
days did show a small negative correlation with primary
care visits (r = -0.03 to r = -0.04). Thus, acutely ill patients
requiring hospitalization could account for some of the
shortened survival noted in this trajectory.
A limitation of this study is its reliance on VA administra-
tive data; out-of-system health care use was not captured
and qualitative data was not available. The scope of the
study precluded chart review of the electronic medical
records from which the administrative data were
extracted. VA patients are predominantly male, reflecting
enlistment practices of the armed services, but they also
tend to be poorer and sicker than US residents in general,
characteristics shared with low-income populations in
general, such as Medicaid patients. Another limitation of
the study is its bias against intermittent users of VA health-
care services, because inclusion in the cohort required at
least two outpatient visits in the baseline year. Potentially
a fifth trajectory of primary care exists in which intermit-
tent users variably use primary care; our study is unable to
address these possibilities. We know that a fairly large per-
cent of VA patients, especially older individuals, utilize
out of system providers (primarily through Medicare, the
federal healthcare insurance program available to US res-
idents over age 65), and this study was unable to examine
such utilization. However, seriously mentally ill patients
have been documented to remain within the VA for their
care more often than other veterans. [29]
The relative value of psychiatric care vs primary care may
be of interest, as these two forms of care may covary or
may diverge, depending on the patient. We noted a mod-
est positive correlation of psychiatric with primary care (r
= .02 to r = .09). An in-depth exploration of this covari-
ance may yield valuable insight.
Other protective factors for these patients were continued
contact with the healthcare system, being married, being
younger, and female gender. Loss of system contact was
Increasing Primary Care – Diabetes Only 0.38 <.0001
Low-Decreasing Primary Care – Diabetes Only 3.85 <.0001
High-Decreasing Primary Care – Diabetes Only 1.59 <.0001
Table 2: Characteristics Associated with Decreased Survival among VA Patients with Diabetes, Schizophrenia, or Both Diabetes and 
Schizophrenia (N = 241,466) (Continued)
Survival Curves by Primary Care Cluster, Diagnostic GroupFigure 4
Survival Curves by Primary Care Cluster, Diagnostic 
Group.Page 9 of 11
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seen inpatient death and again in this study of outpa-
tients. This study reinforces the value of at least annually
using the VA healthcare system, so as to allow clinicians to
review treatment recommendations, including adherence
to psychotropic medications, monitoring blood glucose
and blood pressure, and screening for new problems.
Therefore, outreach to patients who have been out of con-
tact for more than 12 months seems warranted, [30] in
addition to maintaining consistent or higher levels of pri-
mary care.
Conclusion
Older VA patients have a variety of risk factors for prema-
ture death, including comorbidity burden and sub-opti-
mal use of health care services. Life might be extended by
the timely treatment of comorbid physical disease. While
research supports an inverse association between primary
care and mortality, assessing patterns of primary care use
in a cohort of patients offers the potential to illuminate
which patients require outreach, and what patterns of care
may be necessary to improve patient outcomes.
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